作者: Alan Glaxo Wellcome plc Naylor , Ian Baxter Glaxo Wellcome plc Campbell
DOI:
关键词:
摘要: The invention provides the compounds of formula (I) and pharmaceutically acceptable derivatives thereof in which : R?0 R1? are independently selected from H, halogen, C?1-6?alkyl, C1-6alkoxy, or C1-6alkoxy substituted by one more fluorine atoms; R?2? is C1-6alkyl atoms, C1-6hydroxyalkyl, SC1-6alkyl, C(O)H, C(O)C1-6alkyl, C1-6alkylsulphonyl, R?3? C?1-6?alkyl NH2. Compounds potent selective inhibitors COX-2 use treatment pain, fever, inflammation a variety conditions diseases.